<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:  Affordable point-of-use water disinfection through mass-produced nano-silver embedded paper filters</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>04/15/2020</AwardEffectiveDate>
<AwardExpirationDate>12/31/2023</AwardExpirationDate>
<AwardTotalIntnAmount>750000.00</AwardTotalIntnAmount>
<AwardAmount>1265997</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Rajesh Mehta</SignBlockName>
<PO_EMAI>rmehta@nsf.gov</PO_EMAI>
<PO_PHON>7032922174</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The broader impacts of this Small Business Innovation Research (SBIR) Phase II project focuses on the research and development of an antimicrobial nanoparticle filter paper for low-cost point-of-use water purification.  The proposed project will develop an antimicrobial paper water purifier, packaged like a coffee filter, to be distributed through retail channels. This project will offer safe water to many communities throughout the world. &lt;br/&gt;&lt;br/&gt;This SBIR Phase II project will advance the development of a process using large-scale paper machinery and similar reel-to-reel processes to manufacture low-cost nano-metal functionalized materials, such as nanosilver filter paper. Phase II objectives include: (i) optimize the process to reduce materials and other costs, increase flow rate, and maintain high-quality performance, (ii) demonstrate a more robust filter system by mitigation of water chemical and microbiology variability through improved formulation and formal determination of product shelf-life, (iii) demonstrate production at pilot and industrial speeds and output levels, while validating a non-destructive quality control program, and (iv) integrate third-party product safety certification tests.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>04/06/2020</MinAmdLetterDate>
<MaxAmdLetterDate>08/19/2021</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1951210</AwardID>
<Investigator>
<FirstName>Theresa</FirstName>
<LastName>Dankovich</LastName>
<PI_MID_INIT>A</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Theresa A Dankovich</PI_FULL_NAME>
<EmailAddress>teri.dankovich@foliawater.com</EmailAddress>
<PI_PHON>3155592135</PI_PHON>
<NSF_ID>000776511</NSF_ID>
<StartDate>04/06/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>FOLIA WATER, INC.</Name>
<CityName>New York</CityName>
<ZipCode>100144604</ZipCode>
<PhoneNumber>3155592135</PhoneNumber>
<StreetAddress>175 Varick St</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>New York</StateName>
<StateCode>NY</StateCode>
<CONGRESSDISTRICT>10</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>NY10</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>080181077</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>FOLIA WATER, INC.</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[FOLIA WATER, INC.]]></Name>
<CityName>Brooklyn</CityName>
<StateCode>NY</StateCode>
<ZipCode>112261508</ZipCode>
<StreetAddress><![CDATA[710 Parkside Ave]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>New York</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>09</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>NY09</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>097Z</Code>
<Text>COVID-19 Impacts on Existing Activities</Text>
</ProgramReference>
<ProgramReference>
<Code>1238</Code>
<Text>TECH FOR SUSTAINABLE ENVIRONMENT</Text>
</ProgramReference>
<ProgramReference>
<Code>168E</Code>
<Text>SBIR/STTR/ERC Collab (SECO)</Text>
</ProgramReference>
<ProgramReference>
<Code>169E</Code>
<Text>SBIR Tech Enhan Partner (TECP)</Text>
</ProgramReference>
<ProgramReference>
<Code>5383</Code>
<Text>HUMAN &amp;/OR BIOLOGICAL</Text>
</ProgramReference>
<ProgramReference>
<Code>8038</Code>
<Text>Biotechnology</Text>
</ProgramReference>
<ProgramReference>
<Code>8240</Code>
<Text>SBIR/STTR CAP</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0121</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2020~899999</FUND_OBLG>
<FUND_OBLG>2021~365998</FUND_OBLG>
</Award>
</rootTag>
